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Towards Accelerated Medical Innovation 
This talk will explore platform technologies that are currently being developed in 
the KarpLab at the Brigham and Women’s Hospital, Harvard Medical School, to 
tackle medical problems. Namely, minimally invasive sealing of tissues and 
wounds including blood vessels and heart tissue, achieving long term local 
immunosuppression for treatment of vascularized composite allografts, and 
engineered stem cell therapy for treatment of diseases such as multiple sclerosis 
and prostate cancer. Many of the technologies developed in the Karplab harness 
lessons from nature for inspiration, as evolution represents millions and millions of 
years of research and development and thus nature truly is the best problem solver 
(creatures used for inspiration include geckos, spider webs, jellyfish, porcupine 
quills, snails, and spiny headed worms). This talk will also highlight a new research 
model for accelerated medical innovation. Some of the technologies that will be 
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